Potential Cancer Risk with Omalizumab? A Disproportionality Analysis of the Who's Vigibase Pharmacovigilance Database

AuthID
P-00V-5GT
4
Author(s)
Mota, D
·
Tipo de Documento
Letter
Year published
2021
Publicado
in ALLERGY, ISSN: 0105-4538
Volume: 76, Número: 10, Páginas: 3209-3211 (3)
Indexing
Publication Identifiers
Pubmed: 34270120
SCOPUS: 2-s2.0-85110567893
Wos: WOS:000675323700001
Source Identifiers
ISSN: 0105-4538
Export Publication Metadata
Info
At this moment we don't have any links to full text documens.